Clinical Assessment of the Utility of Restage Transurethral Resection of Bladder Tumor (reTURBT)

Abstract

Transurethral resection of bladder tumors (TURBT) is the first step in the initial management of bladder cancer. A TURBT is both diagnostic and therapeutic, and the procedure provides critical staging information. In a TURBT, the configuration (flat, sessile, or papillary), location (trigone, base, dome, or lateral walls), size (cm), and the number of tumors should be recorded. Tumors should be completely resected if they are small, solitary, and available for resection, and also other than superficial appearing low-grade tumors, muscularis propria must be included in the specimen to ensure adequate resection. Management might include directed bladder biopsies of abnormal-appearing urothelium or biopsies of the prostatic urethra. Biopsy or resection of the prostatic urethra should also be considered if the patient has tumor at the bladder neck or if the tumor is within the prostatic urethra. Based on above findings the present study was planned to evaluate the clinical assessment of the utility of restage transurethral resection of bladder tumor (rTURBT). The present study was planned in the Department of Urology Hanumant Hospital,Bhavnagar,Gujarat and Kurji Holy Family Hospital, Patna, Bihar, India. The study was performed from the May 2016 to Dec 2019. Total 30 cases of the proven histological diagnosis of nonmuscle invasive urothelial cancer with either high grade or T1 cancers on histopathology were enrolled in the present study. The data generated from the present study concludes that TURBT is necessary in patients with solid bladder tumors. The presence of tumor at restage confers a higher risk of recurrence and progression. Poor patient compliance for a restage TURBT remains a matter of concern.

Keywords: Turbt, reTURBT, Restage Transurethral Resection of Bladder Tumor, Bihar region, etc.